Oral semaglutide showed superior reductions in blood sugar vs ... - 09 June 2019 01:45

SAN FRANCISCO, June 9, 2019 /PRNewswire-AsiaNet/ -- Abstracts 54-OR and 55-OR Secondary data at 52 weeks demonstrated statistically significant blood sugar reductions and statistically significant reduction of body weight vs both Jardiance(R) and Victoza(R) Findings presented today from two p...

  ESPGHAN Researchers Warn: Junk Food Could Be Responsible for t... - 08 June 2019 09:01

GLASGOW, Scotland, June 8, 2019 /PRNewswire-AsiaNet/-- Experts at the 52nd Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) are today presenting research that shows higher levels of advanced glycation end products (AGEs), found in abundance in ...

  HealthEngine celebrates new milestone for Australian health, r... - 06 June 2019 12:01

PERTH, Australia, June 6, 2019 /PRNewswire-AsiaNet/ -- Aussies are embracing digital health leading to a surge in online healthcare bookings HealthEngine (http://healthengine.com.au/) has solidified its position as Australia's leading consumer healthcare platform, reaching one million monthly boo...

  Spectrum Therapeutics provides update on its global clinical r... - 05 June 2019 21:10

SMITHS FALLS, Ontario, June 5, 2019 /PRNewswire-AsiaNet/ -- Spectrum Therapeutics ("Spectrum"), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the "Company" or "Canopy Growth") is pleased to share an update on its efforts to develop and commercialize validated cannabis medicines...

  Menicon Announces Launch of Menicon Bloom Myopia Control Manag... - 05 June 2019 18:41

NAGOYA, Japan, June 5, 2019 /Kyodo JBN- AsiaNet/ -- - Launch Features Initial Introduction of Menicon Bloom Night, First and Only CE-approved Orthokeratology Contact Lens in Europe for Myopia Control - Menicon Co., Ltd. announced on May 24 the launch of the Menicon Bloom Myopia Control Manag...

  Poor Oral Health Severely Impacts Training and Athletic Perfor... - 05 June 2019 09:00

GENEVA, June 5, 2019 /PRNewswire-AsiaNet/ -- If they want to win, elite and amateur athletes need to make their oral health[https://www.fdiworlddental.org/what-we-do/projects/sports-dentistry] a top priority. FDI World Dental Federation (FDI) couldn't agree more. Today the organization re...

  Cellenkos, Inc. Initiates Phase 1 Clinical Trial of CK0801 for... - 04 June 2019 23:17

HOUSTON, June 4, 2019 /PRNewswire-AsiaNet/ -- Cellenkos, Inc.(http://www.cellenkosinc.com/), announced today the initiation of a Phase 1 Clinical Trial of CK0801, a first-in-class, allogeneic cord blood-derived T-regulatory cell product, for treatment of patients with bone marrow failure synd...

  RemeGen, Ltd. Announces Positive Results from RC48 Clinical Tr... - 04 June 2019 23:00

YANTAI, China, June 4, 2019 /PRNewswire-AsiaNet/ -- --Results, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, demonstrated clinically meaningful response in patients with urothelial carcinoma whose treatment previously failed, a population with high unmet medical...

  New Instrument for Automated Antimicrobial Susceptibility Test... - 04 June 2019 16:00

BASINGSTOKE, England, June 4, 2019 /PRNewswire-AsiaNet/ -- -- Instrument utilizes gold standard broth microdilution method to guide more targeted patient therapy and optimize patient outcomes A new benchtop automated reading and incubation system is now available in Europe for antimicrobial susceptibil...

  Merck Presents Updated Results for Investigational Therapy Tep... - 04 June 2019 07:13

DARMSTADT, Germany , June 4, 2019 /PRNewswire-AsiaNet/ -- ASCO Abstract # Tepotinib (MET kinase inhibitor): 9005 Not intended for UK- , Canada- or US-based media *Alterations of the MET signaling pathway are present in 3-5% of non-small cell lung cancer patients and correlate with poor prognosis ...